CA2453013A1 - Dermal, transdermal, mucosal or transmucosal ingredient delivery devices - Google Patents
Dermal, transdermal, mucosal or transmucosal ingredient delivery devices Download PDFInfo
- Publication number
- CA2453013A1 CA2453013A1 CA002453013A CA2453013A CA2453013A1 CA 2453013 A1 CA2453013 A1 CA 2453013A1 CA 002453013 A CA002453013 A CA 002453013A CA 2453013 A CA2453013 A CA 2453013A CA 2453013 A1 CA2453013 A1 CA 2453013A1
- Authority
- CA
- Canada
- Prior art keywords
- cover
- reservoir
- opening
- liner
- sealing surface
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004615 ingredient Substances 0.000 title claims abstract 12
- 230000002500 effect on skin Effects 0.000 title abstract 2
- 239000010410 layer Substances 0.000 claims abstract 8
- 239000012790 adhesive layer Substances 0.000 claims abstract 6
- 210000004877 mucosa Anatomy 0.000 claims abstract 5
- 239000011248 coating agent Substances 0.000 claims 10
- 238000000576 coating method Methods 0.000 claims 10
- 238000007789 sealing Methods 0.000 claims 8
- 239000000853 adhesive Substances 0.000 claims 7
- 230000001070 adhesive effect Effects 0.000 claims 7
- -1 alkylene glycol Chemical compound 0.000 claims 6
- 230000004888 barrier function Effects 0.000 claims 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 4
- 239000000463 material Substances 0.000 claims 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- 239000011241 protective layer Substances 0.000 claims 3
- 230000015556 catabolic process Effects 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000002131 composite material Substances 0.000 claims 2
- 238000006731 degradation reaction Methods 0.000 claims 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 2
- 229960004889 salicylic acid Drugs 0.000 claims 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical group CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 claims 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- 210000004207 dermis Anatomy 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A dermal, transdermal, mucosal or transmucosal delivery device is provided. The device includes a backing layer, defining an ingredient containing reservoir, a cover for the reservoir having at least one opening therethrough, an adhesive layer and a liner layer. Upon removal of the liner layer, the device may be placed over the desired area of the skin or mucosa and adhesively applied thereto allowing the ingredients to flow from the reservoir through the at least one opening to the dermis or mucosa.
Claims (12)
1. An ingredient delivery device, comprising:
a backing member defining an ingredient containing reservoir, said backing member being made of a material which is substantially impermeable to ingredients contained in said reservoir;
an ingredient contained in said reservoir comprising an organic solution, wherein said organic solution comprises:
a topically active drug agent;
an alkylene glycol;
a fatty acid ester;
a dialkylene glycol alkyl ether; and a polymeric thickening agent;
a cover for said reservoir, said cover being made of a material substantially impermeable to ingredients contained in said reservoir, but having at least one opening therein, such that ingredients to be delivered from said reservoir will flow through said opening, but will not readily flow through said material of which said cover is made;
said cover being sealed to said backing member at the perimeter of said reservoir by a first seal which is not subject to degradation by any ingredient to be contained in said reservoir;
an adhesive layer adhered to said backing member for adhering said device to a patient's skin or mucosa, said adhesive layer not extending to the perimeter of said opening in said cover, such that a portion of said cover surrounding said perimeter of said opening is exposed to thereby define a cover sealing surface; and a liner covering said sealing surface of said cover and said opening in said cover, said liner being releasably sealed to said sealing surface of said cover by a second seal which is not subject to degradation by any ingredient contained in said reservoir; whereby ingredients contained in said reservoir are sealed therein during storage and non-use by said first and second seals, said cover and liner, but are free to flow through said opening and onto a subject's skin or mucosa when said liner is removed from said device and said device is applied to such skin or mucosa.
a backing member defining an ingredient containing reservoir, said backing member being made of a material which is substantially impermeable to ingredients contained in said reservoir;
an ingredient contained in said reservoir comprising an organic solution, wherein said organic solution comprises:
a topically active drug agent;
an alkylene glycol;
a fatty acid ester;
a dialkylene glycol alkyl ether; and a polymeric thickening agent;
a cover for said reservoir, said cover being made of a material substantially impermeable to ingredients contained in said reservoir, but having at least one opening therein, such that ingredients to be delivered from said reservoir will flow through said opening, but will not readily flow through said material of which said cover is made;
said cover being sealed to said backing member at the perimeter of said reservoir by a first seal which is not subject to degradation by any ingredient to be contained in said reservoir;
an adhesive layer adhered to said backing member for adhering said device to a patient's skin or mucosa, said adhesive layer not extending to the perimeter of said opening in said cover, such that a portion of said cover surrounding said perimeter of said opening is exposed to thereby define a cover sealing surface; and a liner covering said sealing surface of said cover and said opening in said cover, said liner being releasably sealed to said sealing surface of said cover by a second seal which is not subject to degradation by any ingredient contained in said reservoir; whereby ingredients contained in said reservoir are sealed therein during storage and non-use by said first and second seals, said cover and liner, but are free to flow through said opening and onto a subject's skin or mucosa when said liner is removed from said device and said device is applied to such skin or mucosa.
2. The device of claim 1, wherein said liner is a release liner for said device, said release liner covering said adhesive layer as well as said sealing surface and said opening of said cover.
3. The device of claim 2, wherein said first and second seals are heat seals between said cover and said backing member and between said liner and said cover respectively.
4. The device of claim 3 in which said liner is a composite member comprising:
an outer protective layer and a barrier layer with an adhesive coating therebetween, and a release coating on the exposed surface of said barrier layer;
said barrier layer, including its adhesive coating and its release coating, having an opening therein which is sufficiently large to expose said opening and said sealing surface of said cover, whereby said outer protective layer is sealed directly to said sealing surface of said cover by said second seal.
an outer protective layer and a barrier layer with an adhesive coating therebetween, and a release coating on the exposed surface of said barrier layer;
said barrier layer, including its adhesive coating and its release coating, having an opening therein which is sufficiently large to expose said opening and said sealing surface of said cover, whereby said outer protective layer is sealed directly to said sealing surface of said cover by said second seal.
5. The device of claim 4 in which said adhesive layer is a composite member comprising:
a first adhesive coating, a second adhesive coating and a barrier layer therebetween;
said barrier layer, including its first adhesive coating and its second adhesive coating, having an opening therein which is sufficiently large to expose said opening and said sealing surface of said cover, whereby said outer protective layer is sealed directly to said sealing surface of said cover by said second seal.
a first adhesive coating, a second adhesive coating and a barrier layer therebetween;
said barrier layer, including its first adhesive coating and its second adhesive coating, having an opening therein which is sufficiently large to expose said opening and said sealing surface of said cover, whereby said outer protective layer is sealed directly to said sealing surface of said cover by said second seal.
6. The device of claim 5, wherein said release coating of said liner is releasably adhered to said second adhesive coating of said adhesive layer.
7. The device of claim 6, wherein said reservoir comprises an absorbable material.
8. The device of claim 7, wherein said topically active drug agent is salicylic acid.
9. The device of claim 8, wherein said salicylic acid is present in an amount of from about 5 % to about 40% by weight of said organic solution.
10. The device of claim 9, wherein said alkylene glycol is propylene glycol.
11. The device of claim 10, wherein said fatty acid ester is glyceryl monoleate
12. The device of claim 11, wherein said dialkylene glycol alkyl ether is diethylene glycol monoethyl ether.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2729967A CA2729967C (en) | 2002-12-13 | 2003-12-11 | Use of a transdermal or transmucosal ingredient delivery device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43320302P | 2002-12-13 | 2002-12-13 | |
US60/433,203 | 2002-12-13 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2729967A Division CA2729967C (en) | 2002-12-13 | 2003-12-11 | Use of a transdermal or transmucosal ingredient delivery device |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2453013A1 true CA2453013A1 (en) | 2004-06-13 |
CA2453013C CA2453013C (en) | 2011-02-15 |
Family
ID=32595136
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2729967A Expired - Fee Related CA2729967C (en) | 2002-12-13 | 2003-12-11 | Use of a transdermal or transmucosal ingredient delivery device |
CA2453013A Expired - Fee Related CA2453013C (en) | 2002-12-13 | 2003-12-11 | Dermal, transdermal, mucosal or transmucosal ingredient delivery devices |
CA2509670A Expired - Lifetime CA2509670C (en) | 2002-12-13 | 2003-12-12 | Dermal, transdermal, mucosal or transmucosal ingredient delivery devices |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2729967A Expired - Fee Related CA2729967C (en) | 2002-12-13 | 2003-12-11 | Use of a transdermal or transmucosal ingredient delivery device |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2509670A Expired - Lifetime CA2509670C (en) | 2002-12-13 | 2003-12-12 | Dermal, transdermal, mucosal or transmucosal ingredient delivery devices |
Country Status (7)
Country | Link |
---|---|
US (1) | US7976867B2 (en) |
EP (1) | EP1596842B1 (en) |
AT (1) | ATE422158T1 (en) |
AU (2) | AU2003297033A1 (en) |
CA (3) | CA2729967C (en) |
DE (1) | DE60326088D1 (en) |
WO (1) | WO2004054638A2 (en) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
US8206738B2 (en) | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US8541021B2 (en) | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
US20050113510A1 (en) | 2001-05-01 | 2005-05-26 | Feldstein Mikhail M. | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
ATE438418T1 (en) * | 2001-05-01 | 2009-08-15 | Av Topchiev Inst Petrochemical | HYDROGEL COMPOSITIONS |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
US6803420B2 (en) | 2001-05-01 | 2004-10-12 | Corium International | Two-phase, water-absorbent bioadhesive composition |
WO2005074894A1 (en) | 2004-01-30 | 2005-08-18 | Corium International | Rapidly dissolving film for delivery of an active agent |
WO2005094526A2 (en) * | 2004-03-24 | 2005-10-13 | Corium International, Inc. | Transdermal delivery device |
US20050261654A1 (en) * | 2004-05-21 | 2005-11-24 | Swanson Paul J | Method and apparatus for warming accessories for diapers and the like |
CN103497713B (en) | 2004-08-05 | 2018-07-17 | 考里安国际公司 | Adhesive composition |
US20070027426A1 (en) * | 2005-06-24 | 2007-02-01 | Transcutaneous Technologies Inc. | Iontophoresis device to deliver active agents to biological interfaces |
RU2008114490A (en) | 2005-09-15 | 2009-10-20 | ТиТиАй ЭЛЛЕБО, ИНК. (JP) | STEM TYPE IONTOPHORESIS DEVICE |
WO2007038028A1 (en) * | 2005-09-28 | 2007-04-05 | Tti Ellebeau, Inc. | Iontophoresis apparatus and method to deliver active agents to biological interfaces |
US20070232983A1 (en) * | 2005-09-30 | 2007-10-04 | Smith Gregory A | Handheld apparatus to deliver active agents to biological interfaces |
JP2009509659A (en) * | 2005-09-30 | 2009-03-12 | Tti・エルビュー株式会社 | Iontophoresis device and method for delivery of active agents to biological interfaces |
US7848801B2 (en) | 2005-12-30 | 2010-12-07 | Tti Ellebeau, Inc. | Iontophoretic systems, devices, and methods of delivery of active agents to biological interface |
WO2007092634A2 (en) * | 2006-02-09 | 2007-08-16 | Christy Frank L | Nasal comfort devices and methods |
DE102007025973A1 (en) | 2007-06-04 | 2008-12-11 | Lts Lohmann Therapie-Systeme Ag | Storage stable laminate sections |
NZ582565A (en) | 2007-07-10 | 2012-07-27 | Agile Therapeutics Inc | Dermal delivery device with in situ seal |
EP2167001A4 (en) * | 2007-07-10 | 2012-10-31 | Agile Therapeutics Inc | Dermal delivery device with ultrasonic weld |
NZ591334A (en) * | 2008-09-05 | 2013-03-28 | Teikoku Pharma Usa Inc | Iontophoretic drug delivery packaging with a folding support including a separator component |
AU2010204986B2 (en) | 2009-01-14 | 2016-06-02 | Corium International, Inc. | Transdermal administration of tamsulosin |
US8781576B2 (en) | 2009-03-17 | 2014-07-15 | Cardiothrive, Inc. | Device and method for reducing patient transthoracic impedance for the purpose of delivering a therapeutic current |
JP5563652B2 (en) | 2009-03-17 | 2014-07-30 | カーディオスライヴ インコーポレイテッド | External defibrillator |
US8828979B2 (en) | 2012-03-27 | 2014-09-09 | Essential Ingredients, Inc. | Salicylic acid gel |
US10299934B2 (en) | 2012-12-11 | 2019-05-28 | Globus Medical, Inc | Expandable vertebral implant |
US9616243B2 (en) | 2013-06-14 | 2017-04-11 | Cardiothrive, Inc. | Dynamically adjustable multiphasic defibrillator pulse system and method |
US10279189B2 (en) | 2013-06-14 | 2019-05-07 | Cardiothrive, Inc. | Wearable multiphasic cardioverter defibrillator system and method |
US9907970B2 (en) | 2013-06-14 | 2018-03-06 | Cardiothrive, Inc. | Therapeutic system and method using biphasic or multiphasic pulse waveform |
US10149973B2 (en) | 2013-06-14 | 2018-12-11 | Cardiothrive, Inc. | Multipart non-uniform patient contact interface and method of use |
US9833630B2 (en) | 2013-06-14 | 2017-12-05 | Cardiothrive, Inc. | Biphasic or multiphasic pulse waveform and method |
US9656094B2 (en) | 2013-06-14 | 2017-05-23 | Cardiothrive, Inc. | Biphasic or multiphasic pulse generator and method |
WO2015089310A1 (en) * | 2013-12-11 | 2015-06-18 | Atkinson Oscar | Occlusive skin covering |
US11607026B2 (en) * | 2014-05-30 | 2023-03-21 | Johnson & Johnson Consumer Inc. | Device for delivery of skin care composition |
US20180289556A1 (en) | 2017-04-11 | 2018-10-11 | Ipcapital Group, Inc. | Wound covering apparatus |
US10828500B2 (en) | 2017-12-22 | 2020-11-10 | Cardiothrive, Inc. | External defibrillator |
CN112274311B (en) * | 2020-09-28 | 2022-11-29 | 江苏爱护佳健康科技有限公司 | Staged physiotherapy umbilical hernia bandage with medicinal bag combined structure |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2561071A (en) * | 1949-09-21 | 1951-07-17 | Prisk Howard Conley | Holder for subcutaneous administration of medicaments |
US2579403A (en) * | 1950-06-01 | 1951-12-18 | Slomowitz Julius | Medical bandage |
US4624665A (en) * | 1984-10-01 | 1986-11-25 | Biotek, Inc. | Method of transdermal drug delivery |
DE8509793U1 (en) * | 1985-04-02 | 1985-05-15 | Allpack Industrielle Lohnverpackung GmbH & Co KG, 7050 Waiblingen | Pharmaco adhesive plaster |
US4743249A (en) * | 1986-02-14 | 1988-05-10 | Ciba-Geigy Corp. | Dermal and transdermal patches having a discontinuous pattern adhesive layer |
DE3775830D1 (en) * | 1986-06-13 | 1992-02-20 | Alza Corp | ACTIVATING A TRANSDERMAL DRUG DELIVERY SYSTEM THROUGH MOISTURE. |
US5344656A (en) * | 1986-09-12 | 1994-09-06 | Alza Corporation | Subsaturated transdermal therapeutic system having improved release characteristics |
US4908027A (en) * | 1986-09-12 | 1990-03-13 | Alza Corporation | Subsaturated transdermal therapeutic system having improved release characteristics |
US4863970A (en) * | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
US4877628A (en) * | 1987-09-03 | 1989-10-31 | International Flavors & Fragrances Inc. | Process for preparing a coated food product |
US4983395A (en) * | 1987-11-12 | 1991-01-08 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
US4849224A (en) * | 1987-11-12 | 1989-07-18 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
US4863738A (en) * | 1987-11-23 | 1989-09-05 | Alza Corporation | Skin permeation enhancer compositions using glycerol monooleate |
GB8804164D0 (en) * | 1988-02-23 | 1988-03-23 | Tucker J M | Bandage for administering physiologically active compound |
US4877618A (en) | 1988-03-18 | 1989-10-31 | Reed Jr Fred D | Transdermal drug delivery device |
US5641504A (en) * | 1988-06-09 | 1997-06-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolinoleate |
US5053227A (en) * | 1989-03-22 | 1991-10-01 | Cygnus Therapeutic Systems | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith |
US4973468A (en) * | 1989-03-22 | 1990-11-27 | Cygnus Research Corporation | Skin permeation enhancer compositions |
US5788983A (en) * | 1989-04-03 | 1998-08-04 | Rutgers, The State University Of New Jersey | Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes |
US5234690A (en) * | 1991-08-23 | 1993-08-10 | Cygnus Therapeutic Systems | Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset |
US5985860A (en) * | 1992-06-03 | 1999-11-16 | Toppo; Frank | System for transdermal delivery of pain relieving substances |
US5462743A (en) * | 1992-10-30 | 1995-10-31 | Medipro Sciences Limited | Substance transfer system for topical application |
KR100212961B1 (en) * | 1992-12-31 | 1999-08-02 | 조민호 | Trasdermal drug delivery system |
DE4341444C2 (en) * | 1993-12-04 | 1996-03-14 | Lohmann Therapie Syst Lts | Active substance-containing plaster and process for its production |
US5962011A (en) * | 1993-12-06 | 1999-10-05 | Schering-Plough Healthcare Products, Inc. | Device for delivery of dermatological ingredients |
US5641507A (en) * | 1993-12-06 | 1997-06-24 | Devillez; Richard L. | Delivery system for dermatological and cosmetic ingredients |
US5851549A (en) * | 1994-05-25 | 1998-12-22 | Becton Dickinson And Company | Patch, with system and apparatus for manufacture |
WO1996019205A1 (en) | 1994-12-21 | 1996-06-27 | Theratech, Inc. | Transdermal delivery system with adhesive overlay and peel seal disc |
GR1002807B (en) * | 1996-06-20 | 1997-11-13 | Lavipharm A.E. | Device for topical treatment of acne and method of manufacture. |
US6007837A (en) * | 1996-07-03 | 1999-12-28 | Alza Corporation | Drug delivery devices and process of manufacture |
AU4990797A (en) * | 1996-10-24 | 1998-05-15 | Alza Corporation | Permeation enhancers for transdermal drug delivery compositions, devices, and methods |
US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
IT1294748B1 (en) * | 1997-09-17 | 1999-04-12 | Permatec Tech Ag | FORMULATION FOR A TRANSDERMAL DEVICE |
AP1224A (en) | 1998-03-19 | 2003-11-14 | Bristol Myers Squibb Co | Biphasic controlled release delivery system for high solubility pharmaceuticals and method. |
US6275728B1 (en) * | 1998-12-22 | 2001-08-14 | Alza Corporation | Thin polymer film drug reservoirs |
DE19949202A1 (en) | 1999-10-13 | 2001-05-03 | Lohmann Therapie Syst Lts | Transdermal therapeutic system for the delivery of acetylsalicylic acid and / or salicylic acid |
-
2003
- 2003-12-11 CA CA2729967A patent/CA2729967C/en not_active Expired - Fee Related
- 2003-12-11 CA CA2453013A patent/CA2453013C/en not_active Expired - Fee Related
- 2003-12-12 AU AU2003297033A patent/AU2003297033A1/en not_active Abandoned
- 2003-12-12 AT AT03813429T patent/ATE422158T1/en not_active IP Right Cessation
- 2003-12-12 CA CA2509670A patent/CA2509670C/en not_active Expired - Lifetime
- 2003-12-12 DE DE60326088T patent/DE60326088D1/en not_active Expired - Lifetime
- 2003-12-12 WO PCT/US2003/039717 patent/WO2004054638A2/en not_active Application Discontinuation
- 2003-12-12 EP EP03813429A patent/EP1596842B1/en not_active Expired - Lifetime
- 2003-12-12 US US10/735,318 patent/US7976867B2/en active Active
-
2009
- 2009-10-30 AU AU2009233617A patent/AU2009233617B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CA2729967C (en) | 2018-01-16 |
WO2004054638A3 (en) | 2004-08-12 |
CA2729967A1 (en) | 2004-06-13 |
US20040166147A1 (en) | 2004-08-26 |
CA2453013C (en) | 2011-02-15 |
EP1596842B1 (en) | 2009-02-04 |
AU2003297033A1 (en) | 2004-07-09 |
CA2509670C (en) | 2012-03-13 |
DE60326088D1 (en) | 2009-03-19 |
AU2009233617B2 (en) | 2011-05-12 |
CA2509670A1 (en) | 2004-07-01 |
WO2004054638A2 (en) | 2004-07-01 |
ATE422158T1 (en) | 2009-02-15 |
US7976867B2 (en) | 2011-07-12 |
EP1596842A4 (en) | 2006-03-15 |
AU2009233617A1 (en) | 2009-11-26 |
EP1596842A2 (en) | 2005-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2453013A1 (en) | Dermal, transdermal, mucosal or transmucosal ingredient delivery devices | |
US4627429A (en) | Storage-stable transdermal adhesive patch | |
US6277401B1 (en) | Drug delivery device | |
US7921999B1 (en) | Peelable pouch for transdermal patch and method for packaging | |
US6884920B2 (en) | Hydrocolloid window catheter dressing and a method for making and using the same | |
ES2214822T3 (en) | PATCH WITH ADHESIVE MATRIX. | |
CA2638743A1 (en) | Transdermal patch incorporating active agent migration barrier layer | |
SK278995B6 (en) | Method for producing transdermal therapeutic plaster | |
CA2338859A1 (en) | Estradiol-containing patch for transdermal administration of hormones | |
JP5394083B2 (en) | Patch packaging structure | |
KR101172131B1 (en) | Patch package structure | |
JP2004344389A (en) | Manufacturing method for wound protecting agent | |
JP3052982U (en) | Hand pack | |
JP3167793U (en) | Wound protection film formation kit | |
CA2384739A1 (en) | Plastic films, especially for use in a dermal or transdermal therapeutic system | |
JP3097995U (en) | Wound protection plaster | |
US10864172B2 (en) | Transdermal patch for oil delivery | |
JP3460092B2 (en) | Method for producing ointment-based patch | |
JPH08252299A (en) | Package for patch | |
RU73783U1 (en) | DEVICE FOR LOCALIZED TRANSDERMAL INTRODUCTION OF AN ACTIVE SUBSTANCE | |
JP2000169366A (en) | Sustainable, thick-coated anti-inflammatory/analgesic plaster |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20201211 |